Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange

Rhea-AI Summary

Cannara Biotech (TSX: LOVE | OTCQX: LOVFF) announced an uplisting to the Toronto Stock Exchange and highlighted large-scale production capacity in Québec. The company owns two mega facilities totaling over 1,600,000 sq. ft. with 100,000 kg potential annualized cultivation output and low electricity costs supporting efficient operations.

The company positions itself as a vertically integrated producer of premium cannabis and cannabis-derivative products, citing award-winning SKUs and national retail reach as growth levers.

Positive

• Uplisting to TSX increases market access and visibility
• 1,600,000 sq. ft. of cultivation facilities
• 100,000 kg potential annualized cultivation output
• Low electricity costs in Québec support production efficiency
• Award-winning product portfolio aiding retail resonance

Negative

• None.

Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Cannara Biotech Inc. (TSX: LOVE) (OTCQX: LOVFF) (FSE: 8CB0) is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian market. The company recently uplisted to the Toronto Stock Exchange as it continues to build on its position as one of Canada's fastest-growing cannabis companies. The Company owns two mega facilities based in Québec spanning over 1,600,000 sq. ft., providing 100,000 kg of potential annualized cultivation output. Leveraging Québec's low electricity costs, Cannara combines large-scale, efficient production with a portfolio of award-winning products that resonate with consumers and retailers across Canada.

Cannara Biotech (TSX: LOVE) (OTCQX: LOVFF) (FSE: 8CB0)
https://www.cannara.ca/

Cannot view this video? Visit:
www.b-tv.com/gm-equities/ceo-clips---cannara-biotech-expands-cannabis-production-with-mega-facilities-btv-60

About BTV - Business Television:

For over 25 years, BTV has been a capital markets focused TV production and Digital Marketing Agency. BTV helps companies increase their brand awareness to a national retail and institutional investor audience, combining unique content creation and major distribution services on top tier networks including Bloomberg, CNBC, FOX Business News and financial sites. The BTV suite of strategic products include: BTV- Business Television Show, CEO Clips™, TV Branding Ads, Digital, Lead Gen, Social and Direct Email Marketing Campaigns that reach investors where they research and live on-air and online.

Discover Investment Opportunities!

www.b-tv.com/theagency

About CEO Clips:
CEO Clips - are short company video profiles broadcast to a large audience of investors on TV and 15+ financial sites including Reuters, Yahoo!Finance, and Wall Street Journal.

Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/289140

FAQ

Why did Cannara Biotech (OTCQX: LOVFF) uplist to the Toronto Stock Exchange on March 19, 2026?

The uplisting aims to increase liquidity and investor visibility on a senior Canadian exchange. According to the company, moving to the TSX supports broader investor access while aligning the listing with its national growth and capital-raising strategy.

What is Cannara Biotech's cultivation capacity after expanding its Québec facilities?

Cannara reports a potential annualized cultivation output of 100,000 kg across its facilities. According to the company, two mega sites total over 1,600,000 sq. ft., which underpins scaled production for Canadian retail demand.

How do Québec electricity costs affect Cannara Biotech's production economics?

Lower electricity costs in Québec help reduce cultivation operating expenses and improve unit economics. According to the company, leveraging regional energy advantages enables more efficient large-scale production compared with higher-cost provinces.

What products and markets does Cannara Biotech (TSX: LOVE) serve following the uplisting?

Cannara sells premium-grade cannabis and cannabis-derivative products across Canada, targeting consumers and retailers. According to the company, its award-winning portfolio is positioned for national retail distribution supported by large-scale production.

Does the Cannara Biotech uplisting to TSX affect shareholders of OTCQX: LOVFF immediately?

The uplisting primarily changes the company’s primary exchange to the TSX and aims to improve market visibility. According to the company, existing OTCQX trading remains but the TSX listing provides a senior-market trading venue for shareholders.